Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

Sanofi reception

Sanofi exits Zynquista alliance with Lexicon

Will pay $260m to end collaboration

- PMLiVE

Democrats reveal pricing plan with 250-drug hit list

Listed drugs are costing Medicare the most each year

- PMLiVE

Mallinckrodt offloads CDMO for $250m

Move follows US opioid settlement

- PMLiVE

Merck takes evobrutinib for MS into phase 3, on mixed data

First drug in class to reach this stage for the illness

Synergy Vision completes pilot of four-day working week

Agency will formalise the initiative following improved productivity

- PMLiVE

The power of high-value, highly relevant content to support clinical decisions

by Sandrine Veillet

Spotlight interview: 15 minutes on patient-centricity in pharma

Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

OPEN Health

- PMLiVE

Novartis’ CAR-T Kymriah scores SMC approval

Will now be available on NHS across the UK

- PMLiVE

Boehringer bags FDA OK for Ofev in rare lung disease ILD

First drug approved for condition

- PMLiVE

Prescription drug dependence ‘linked to deprivation’, says PHE

Public Health England publishes review on prescription rates

- PMLiVE

Breaking free

Pharma’s ability to understand and modify customer behaviour is improving – but is it doing enough?

AstraZeneca AZ

Can AZ’s Imfinzi challenge Tecentriq in small cell lung cancer?

New data shows improvement in overall survival

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links